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Abstract
Psychotherapies may work through techniques that are specific to each ther-
apy or through factors that all therapies have in common. Proponents of the
common factors model often point to meta-analyses of comparative out-
come studies that show all therapies have comparable effects. However, not
all meta-analyses support the common factors model; the included studies
often have several methodological problems; and there are alternative expla-
nations for finding comparable outcomes. To date, research on the working
mechanisms and mediators of therapies has always been correlational, and
in order to establish that a mediator is indeed a causal factor in the recov-
ery process of a patient, studies must show a temporal relationship between
the mediator and an outcome, a dose–response association, evidence that no
third variable causes changes in the mediator and the outcome, supportive
experimental research, and have a strong theoretical framework. Currently,
no common or specific factor meets these criteria and can be considered
an empirically validated working mechanism. Therefore, it is still unknown
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INTRODUCTION
It is well established that psychotherapies can effectively treat mental disorders, including de-
pression (Barth et al. 2013, Mohr et al. 2014), anxiety disorders (Cuijpers et al. 2014a, 2016a;
Mayo-Wilson et al. 2014; Pompoli et al. 2018), posttraumatic stress disorder (PTSD; Cusack et al.
2016, Gerger et al. 2014), obsessive–compulsive disorder (Olatunji et al. 2013), psychotic disor-
ders (Velthorst et al. 2015), eating disorders (Godfrey et al. 2015), bipolar disorder (Chatterton
et al. 2017, Oud et al. 2016), and personality disorders (Cristea et al. 2017). The effects of these
therapies have been demonstrated in randomized controlled trials (RCTs). From a scientific per-
spective, these trials have a strong design, and when positive effects from a therapy are found,
this can be considered strong evidence that a therapy is indeed effective. However, showing that
a therapy is effective in treating a mental disorder does not provide evidence about how a therapy
works (Kazdin 2007). As we see later in this review, showing how a therapy works is much more
complicated, requires a whole series of studies and experiments, and will never have the strength
of evidence of RCTs showing that a therapy works.
The consequence of this complexity of showing how psychotherapies work is that little is
known about the mechanisms of change of these therapies. Although there are many different
kinds of therapy, and most therapies were developed with a clear theoretical explanation of how
the therapy is supposed to bring about change in the patient, the actual scientific knowledge about
these mechanisms is limited. This lack of knowledge has resulted in different views and models of
how therapies work—the so-called mechanisms of change or action—but none of these models
has sufficient empirical support. The majority of these models explain the effectiveness of thera-
pies through specific effects. Specific effects are those that are realized through the approach of
the therapy. For example, cognitive therapies are assumed to realize their effects through changing
maladaptive cognitions in patients, and behavioral therapies realize their effects through changing
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maladaptive behaviors, both of which are in keeping with the theoretical models these therapies
are based on.
However, there is an alternative model that says that the effects of therapies are not or not only
realized by these specific effects, but instead are realized predominantly through common factors.
These common factors—also often called nonspecific or universal factors—are those factors that
all therapies have in common, such as the alliance between the patient and the therapist, expec-
tations, and a rationale that helps patients understand why they have problems and what can be
done about them.
In this review, we first describe the most important theoretical models of common factors and
how they are assumed to work. Then we focus on comparative outcome research and component
studies because these types of studies and the findings that all therapies seem to have comparable
effects were the starting point for the common factors model. We discuss the research that is
needed to find out how psychotherapy works. Then we discuss the most important common
factors, including the therapeutic alliance, empathy, and expectations, as well as the evidence
supporting these factors as the active ingredients of therapies. We end by discussing the most
important findings and future directions for examining common factors and other potential
mechanisms of change.
COMMON FACTORS: DEFINITION AND MODELS
The notion that all therapies work through common factors was first introduced by Saul Rosen-
zweig (1907–2004) in 1936 (Rosenzweig 1936). He observed that all therapies resulted in compa-
rable outcomes, and based on this observation, he suggested that they probably worked through
factors that were common to them all. He also used an analogy to the Caucus-race in Lewis Car-
roll’s Alice’s Adventures in Wonderland, in which the Dodo suddenly announces the end of a race
and states that, “Everybody has won, and all must have prizes” (Carroll [1865] 1998, p. 34). This
Dodo Bird Verdict, indicating that all therapies have comparable effects and do not significantly
differ from one another, has become a much-discussed issue and the subject of heated debate in
the psychotherapy literature (Budd & Hughes 2009, Cuijpers 1998, Luborsky et al. 2002, Marcus
et al. 2014).
Since Rosenzweig’s statement, several models of common factors have been developed. The
most influential early model was developed by Jerome Frank, who wrote a book in the early 1960s
which became the basis of the modern views on common factors. In his book Persuasion and Heal-
ing: A Comparative Study of Psychotherapy (Frank 1961), he described four nonspecific factors that
were common to all therapies and were assumed to be the working elements of these therapies: a
functioning relationship between patient and therapist, a rationale that provides credibility to the
treatment being delivered, certain procedures or rituals that are provided in a structured manner,
and a healing context or setting.
The best developed andmost modern common factors model, however, is the contextual model
(Wampold 2001, 2015;Wampold & Imel 2015). This model is intended to be an alternative to the
medical model in which therapies are supposed to work through specific ingredients that are “pur-
portedly beneficial for particular disorders due to remediation of an identifiable deficit” (Wampold
2015, p. 270). In the contextual model, a patient and a therapist first have to create a basic bond
to work together. After the establishment of this initial bond, therapy is hypothesized to work
through three pathways. The first pathway is the real relationship, defined as “the personal rela-
tionship between therapist and patient marked by the extent to which each is genuine with the
other and perceives/experiences the other in ways that befit the other” (Gelso 2014, p. 119). This
relationship is assumed to provide the patient with a connection to a caring and empathic person.
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Table 1 Overview of common factors in psychotherapy outcomesa
Common factors
Support Learning Action
Catharsis Advice Behavioral regulation
Identification with therapist Affective experience Cognitive mastery




Positive relationship Cognitive learning Taking risks
Reassurance Corrective emotional experience Mastery efforts
Release of tension Feedback Modeling
Structure Insight Practice
Therapeutic alliance Rationale Reality testing
Active participation of both
therapist and client
Exploration of internal frame of
reference
Experiencing success






aTable adapted with permission from Lambert & Ogles (2004).
This connection is assumed to be healing in itself, especially for patients with suboptimal social
relationships. The second pathway is through a patient’s expectations or hope. Therapies provide
an explanation or rationale for how the patient developed the mental disorder and what can be
done about it. The therapy provides patients with the means to cope with their problems. Thera-
pies give patients hope that they are capable of doing the tasks necessary to complete therapy, and
when these tasks are completed, the problems will be able to be coped with. The third pathway
consists of the specific ingredients of therapies. These specific ingredients create expectations in
patients (thereby activating pathway two) and also produce some salubrious actions (Wampold
2015). These actions differ across therapies; for example, they may improve a patient’s social re-
lationships (interpersonal psychotherapy), aid the patient in adopting helpful ways of thinking
(cognitive behavioral therapy), or help a patient become more accepting toward him- or herself
(acceptance and commitment therapy). It is not assumed that these specific ingredients exert a di-
rect effect through the medical model by repairing an apparent deficit, but rather that, in general,
they stimulate healthy actions that are beneficial to patients.
The term common factors can be conceptualized in different ways. Lambert & Ogles (2004)
gave an overview of the different common factors that can be derived from the literature (Table 1).
As can be seen inTable 1, the factors are grouped into categories of support, learning, and action.
These categories are based on the sequential order of change that is hypothesized to happen dur-
ing psychotherapy. For example, a strong therapeutic alliance can lead to a corrective emotional
experience, which then leads to patients facing their fears or dealing with their problems (Huibers
& Cuijpers 2015). However, this sequential process of change is a theoretical assumption that has
yet to be confirmed by empirical research. It is beyond the scope of this review to describe all
common factors in detail, but in the section Evidence for Selected Common Factors, we discuss
the research on the most important common factors, including the therapeutic alliance between
a therapist and a patient. We also describe how complicated it is to empirically prove that these
factors are indeed directly causing change in patients.
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In 1992, a pie chart was published that displayed how much of the change in patients receiv-
ing psychotherapy could be attributed to common factors, expectations, or placebo effects, and to
specific factors, as well as to factors outside the therapy (Lambert 1992). This chart indicated that
30% of the change can be attributed to common factors and 15% to specific factors (and 40%
to extratherapy factors and 15% to the placebo effect). Although this pie chart appeals to many
clinicians due to its simplicity (echoing the sentiment that “it’s all about the relationship”), and is
often referred to as if these were empirical estimates, the numbers in the chart are in fact no more
than rough estimates of correlates based on impressions from the literature. There is no empirical
evidence to support the percentages given in the chart. There is one meta-analysis of nondirective
supportive counseling in which an attempt was made to estimate improvement rates under control
conditions (change through extratherapy and placebo factors), additional improvement in coun-
seling (the common factors), and the superior effects of specific therapies above counseling (the
specific effects) (Cuijpers et al. 2012). The estimates found in this study did not differ considerably
from the estimates of Lambert (1992), with extratherapeutic factors being responsible for about
one-third of the improvement (33.3%), nonspecific factors responsible for about half (49.6%), and
specific factors responsible for the remaining sixth and smallest share (17.1%). However, these
findings should be considered with great caution because this meta-analysis also found that the
difference between counseling and specific therapies was heavily influenced by a researcher’s al-
legiance, and the risk of bias in the majority of the included studies was considerable (Cuijpers
et al. 2012). This means that true estimates of the contribution of specific and nonspecific factors
cannot be based on this meta-analysis either or on any other meta-analysis, as a matter of fact.
DO ALL THERAPIES HAVE COMPARABLE EFFECTS?
The discussion about whether therapies work through specific or nonspecific factors started with
the Dodo Bird Verdict, the observation that all (or most) therapies have comparable effects. In
this section, we summarize the knowledge about whether all therapies do indeed have comparable
effects by reviewing meta-analyses of comparative outcome trials.
The best way to examine whether two types of therapy have comparable effects is to conduct
trials in which patients are randomized to one of the two therapies and then examine whether
the improvement in participants is comparable between the two therapies. Many such compar-
ative outcome trials have been conducted during the past decades, and dozens of meta-analyses
have pooled the results of these trials. For proponents of the common factors model, the com-
parable effectiveness of therapies is one of the cornerstones that is supposed to prove their claim
that all therapies work through common factors. They would predict that meta-analyses of these
comparative trials indicate no significant differences between therapies. However, proponents of
specific effects assume that such differential effects are entirely possible but not necessary in all
cases. So who is right?
In this section, we first give an overview of the results of meta-analyses that have been con-
ducted during the past 10 years that compared two types of therapy. As we show, some of these
meta-analyses indeed point toward comparable effect sizes for the examined therapies, but others
do not. Therefore, we describe how these results can be interpreted, why proponents of the com-
mon factors model argue that the significant differences found in meta-analyses are only artifacts,
and whether these results can be seen as evidence for the common factors model.
What Can We Learn from Meta-Analyses of Comparative Outcome Studies?
According to the common factorsmodel,meta-analyses of comparative studies should first find no,
or only small and nonsignificant, differences because all therapies are assumed to have comparable
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effects.However, in the common factors model it is also expected that there is no statistical hetero-
geneity. Heterogeneity is the variability in effect sizes that is found in a meta-analysis. It is present
when the observed effect sizes are more different from each other than what would be expected
due to chance (random error) alone (Cuijpers 2016). The common factors model assumes that all
therapies have comparable effects, so heterogeneity should be low because there is no variability in
effect sizes that can be caused by differences between therapies.Heterogeneity is usually measured
in meta-analyses through I2, which is an indication of heterogeneity in percentages (Higgins et al.
2003). An I2 of 25% indicates low heterogeneity, 50% indicates moderate, and 75% indicates high.
In Table 2, we summarize the results of meta-analyses of comparative outcome studies. We
have focused on meta-analyses of broad categories of mental disorders (depression, anxiety dis-
orders, PTSD, obsessive–compulsive disorder, psychosis, and bipolar, eating, and borderline per-
sonality disorders) that reported standardized mean differences (SMD, also called Cohen’s d or
Hedges’s g), were conducted during the past 10 years, and included at least 10 comparisons be-
tween two therapies.
As can be seen from Table 2, several meta-analyses do indeed find nonsignificant differen-
tial effects between therapies with low heterogeneity. For example, cognitive behavioral therapy
(CBT) versus supportive therapy for depression has a small, nonsignificant effect size (SMD =
0.10) and low heterogeneity (I2 = 27%) (Cuijpers et al. 2013). Other meta-analyses, however, find
a significant differential effect and higher levels of heterogeneity. For example, eye movement
desensitization and reprocessing (EMDR) has been found to be significantly more effective than
CBT, with a differential effect size of SMD = −0.43 and with high heterogeneity (I2 = 75%)
(Chen et al. 2015).
Recently, a number of network meta-analyses of the effects of psychotherapies have been pub-
lished (Barth et al. 2013, Gerger et al. 2014, Kriston et al. 2014, Linde et al. 2015, Mayo-Wilson
et al. 2014, Pompoli et al. 2018, Skapinakis et al. 2016, Slade et al. 2018). Network meta-analyses
include multiple comparisons in one analysis, and they include both direct evidence of the ef-
fects of therapies (e.g., from studies directly comparing therapy A with therapy B) and indirect
evidence (e.g., from studies comparing therapy A with control group C, and studies comparing
therapy B with the same control group C). If both A and B have comparable effect sizes compared
with control condition C, then that strengthens the evidence that A and B are indeed compara-
ble. Therefore, network meta-analyses make optimal use of all available evidence and are supe-
rior to conventional meta-analyses from that perspective. It is beyond the scope of this article
to comprehensively review these studies, but overall they show the same pattern as conventional
meta-analyses. For some comparisons, significant differential effects for therapies are found, and
nonsignificant differences are found for others. For example, Mayo-Wilson and associates (2014)
found significantly better effects for CBT compared with psychodynamic therapies for treating
social anxiety disorders [d = −0.56; 95% confidence interval (CI), −1.03 to −0.11], but no sig-
nificant difference between psychodynamic therapy and exposure and social skills training. Barth
and associates (2013) did not find a significant difference between CBT and behavioral activation
therapy for treating depression, but they did find a significant difference between interpersonal
psychotherapy and supportive counseling (d = −0.16; 95% CI, −0.33 to 0.22).
One problem with the level of heterogeneity found in meta-analyses is that this estimate has
its own level of uncertainty (measurement error); therefore, calculating 95% confidence intervals
around I2 is recommended (Ioannidis et al. 2007). Usually these confidence intervals are wide
when the number of studies is small. So in our example of the meta-analysis comparing CBT with
supportive therapy, we found low heterogeneity (I2 = 27%), but the confidence interval ranged
from 0% to 59%. This means that we actually do not know what the true level of heterogeneity
is, and it could range from zero to a moderate or high level. Therefore, the second hypothesis of
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Table 2 Meta-analyses of comparative outcome trials of psychotherapiesa
Study Disorder Therapy Control k SMD 95% CI I2 95% CIc
Baardseth et al. 2013 Anxiety disorders CBT Other therapies 13 0.14 −0.08 to 0.35 69
Bisson et al. 2013 PTSD TFCBT Other therapies 10 0.48b 0.14 to 0.83 69 29 to 82
Braun et al. 2013 Depression CBT Other therapies 41 −0.01 −0.10 to 0.08 5 0 to 68
Behavior
activation
Other therapies 16 −0.08 −0.30 to 0.14 52 17 to 87
Psychodynamic Other therapies 11 0.19 −0.01 to 0.40 44 0 to 91
IPT Other therapies 10 −0.09 −0.30 to 0.13 39 0 to 88
Supportive
therapies
Other therapies 17 0.14 0.00 to 0.29 22 0 to 71
Chen et al. 2015 PTSD CBT EMDR 11 −0.43b −0.86 to −0.01 75 49 to 85
Cuijpers et al. 2018 Depression PST Other therapies 12 0.18b 0.01 to 0.35 27 0 to 63
Cuijpers et al. 2016b Depression IPT Other therapies 14 0.06 −0.14 to 0.26 52 0 to 72
Cuijpers et al. 2013 Depression CBT Supportive
therapies
16 0.10 −0.06 to 0.25 27 0 to 59
Cuijpers et al. 2012 Depression NDST Other therapies 30 −0.20b −0.32 to −0.08 30
Driessen et al. 2015 Depression Psychodynamic Other therapies 15 −0.25b −0.49 to −0.02 63 24 to 77
Grenon et al. 2018 Eating disorders CBT Other therapies 11 0.31b 0.16 to 0.46 0
Kivlighan et al. 2015 Anxiety, depression,
PDs, bulimia,
anorexia, PTSD








Other therapies 10 0.54b 0.26 to 0.83 23 0 to 63
Shinohara et al. 2013 Depression BT Other therapies 18 −0.03 −0.20 to 0.15 0 0 to 43





Psychodynamic Other therapies 23 −0.15b −0.23 to −0.08 0 0 to 40
Turner et al. 2014 Psychotic disorders CBT Other therapies 22 0.16b 0.04 to 0.28 12 0 to 48
Befriending Other therapies 11 −0.37b −0.60 to −0.13 53 0 to 75
Cognitive
remediation
Other therapies 11 0.13 −0.05 to 0.31 32 0 to 65
Social skills
training
Other therapies 16 0.06 −0.17 to 0.28 67 38 to 79
Supportive
counseling
Other therapies 17 0.00 −0.21 to 0.22 60 23 to 75
Abbreviations: BT, behavioral therapy; CBT, cognitive behavioral therapy; CI, confidence interval; EMDR, eye movement desensitization and reprocessing;
IPT, interpersonal psychotherapy; NDST, nondirective supportive therapy; PD: personality disorder; PST, problem-solving therapy; PTSD, posttraumatic
stress disorder; SMD, standardized mean difference; TFCBT, trauma-focused cognitive behavioral therapy.
aWe conducted a systematic search for comparative meta-analyses in PubMed, PsycINFO, and the Cochrane Database of Systematic Reviews in which we
combined search terms (key words and text words) for psychotherapy, mental disorders, and words indicating comparative studies.We selected conventional
meta-analyses comparing two types of psychotherapy that reported the SMD, 95%CI, and I2 (heterogeneity) and that had been published since 2010 (search
date, June 19, 2018).
bp < 0.05.
cEmpty cells in this column indicate that the 95% CI of I2 was not given and could not be reproduced based on the published data.
the common factors model (i.e., there should be low levels of heterogeneity in meta-analyses of
comparative trials) is difficult to validate, especially through meta-analyses of small numbers of
studies.
Some meta-analyses do not focus on the comparative effects of two therapies but instead focus
on any trial that compares any kind of therapy with any other kind of therapy (Marcus et al. 2014,
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Wampold et al. 1997). The problem with this kind of meta-analysis is that the direction of the
outcome is not clear. Suppose that CBT is compared with psychodynamic therapy in a trial, and
psychodynamic therapy is found to be superior. Is that a positive effect size for psychodynamic
therapy or a negative effect size for CBT? Both options are equally valid. This is not a problem
when, for example, psychodynamic therapy is compared with any other therapy because then one
can say that a positive effect size indicates that psychodynamic therapy is superior to other thera-
pies. But if all comparisons for any therapy are included in a meta-analysis, one can choose both
directions, positive for psychodynamic or negative for CBT, and there is no way of resolving the
issue. In these types of meta-analysis, this problem is solved by giving all effect sizes a positive
direction (i.e., it is assumed that there is no difference anyway, so the pooled effect gives only the
upper limit of the differential effect) or by randomly assigning the direction of the effect size across
the studies. The original study that developed this method of meta-analysis showed no significant
difference between therapies (Wampold et al. 1997). However, since then, so many more specific
meta-analyses have been conducted that directly compare two therapies with each other that an
overall meta-analysis using this methodology would be a huge enterprise and, to the best of our
knowledge, this has not been done.
How Can Differences Between Therapies Be Explained by the Common Factors
Model?
Proponents of the common factors model say that when a meta-analysis shows a significant differ-
ential effect size and has a high level of heterogeneity, this is the result of artifacts of the included
comparative trials, and it does not represent true differences between treatments. They give sev-
eral reasons for this.
One important reason why some comparative outcome studies may find differences between
therapies is that some therapies are not bona fide therapies. These therapies are “designed to fail”
and have been called “intent-to-fail” treatments (Westen et al. 2004). Researchers working from
a specific model of therapy (cognitive, behavioral, psychodynamic, interpersonal, or any other
specific model) want to compare their therapy with another therapy to show that their therapy
works. But often, this control therapy is not really intended to have a therapeutic effect and only
mimics the therapeutic situation, without meeting the criteria for a bona fide therapy. Bona fide
therapies can be defined as therapies that are “based on psychological principles, [are] offered to
the psychotherapy community as viable treatments (e.g., through professional books or manuals),”
and are “delivered by trained therapists” (Wampold et al. 1997, p. 205). Proponents of the common
factors model would say that only comparisons of bona fide therapies can give a fair indication of
whether therapies do indeed differ significantly from each other. For example, in a meta-analysis
of trials comparing CBT for depression with other therapies, it was found that CBT was superior
to other therapies (Gloaguen et al. 1998). However, when the other therapies were separated into
bona fide and non–bona fide therapies, it was found that CBT was no more effective than other
bona fide therapies (Wampold et al. 2002).
In many of the comparisons inTable 2, the only therapies compared are those that can be con-
sidered bona fide therapies. However, the decision about whether a therapy is bona fide requires
a judgment from expert raters, and these judgments have not been made in all meta-analyses. So
in meta-analyses comparing a specific type of therapy with the category all other therapies, it is
possible that this category includes non–bona fide therapies. This could explain why some meta-
analyses find superior effects for a therapy when it is compared with the category other therapies.
However, this cannot explain why, for example, EMDR has been found to be more effective than
CBT in treating PTSD (Chen et al. 2015) because both are bona fide therapies.
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Another important reason why comparative outcome studies may find differences between
therapies and still fit into the common factors model is known as researcher allegiance. This can
be defined as the “belief in the superiority of a treatment [and] it usually also entails a belief in
the superior validity of the theory of change that is associated with the treatment” (Leykin &
DeRubeis 2009, p. 55). The assumption is that researchers with an allegiance toward one type of
therapy are inclined to design or interpret the results of a comparative study in such a way that their
preferred therapy is found to be superior to other therapies. This can be seen as a specific type of
intellectual conflict of interest (Cristea& Ioannidis 2018). Indeed, there is evidence that researcher
allegiance can have an impact on the outcomes of comparative outcome studies. A systematic
review of 29 meta-analyses reporting on researcher allegiance found that the correlation between
the outcome of an intervention and allegiance was r= 0.26, which can be seen as a moderate effect
size (corresponding to SMD = 0.54) (Munder et al. 2013).
It is not clear how allegiance works. The assumption is that it favors the preferred therapy
over the other therapy, for example in terms of the number of sessions that participants undergo,
the training of therapists, and supervision. Another possibility, for which some support exists, is
that allegiance works through the risk of bias. Risk of bias refers to the validity of a trial or the
weak spots of a trial (Cuijpers & Cristea 2016). It is usually assessed with the Cochrane Risk of
Bias assessment tool (Higgins et al. 2011). The tool rates whether the randomization has been
done correctly and by an independent person, whether outcome assessors were blinded, whether
all randomized patients were included in the analyses, and whether only selected outcomes (the
positive ones) are reported. There is some evidence that allegiance is indeed associated with the
risk of bias (Munder et al. 2011), and it may be the case that allegiance is a problem only in studies
with a high risk of bias and not in those with a low risk of bias.
Can Comparable Effects Be Seen as Evidence for the Common Factors Model?
Some meta-analyses find clear differences between the effects of therapies, suggesting that thera-
pies can have effects that are specific to that therapy. However, proponents of the common factors
model say that this may be true, but these differences can always be explained by the inclusion of
non–bona fide therapies or those that are intended to fail and by researcher allegiance. This has
not been systematically assessed in all meta-analyses, so whether it is true cannot be determined.
Thus, it may or may not be true that all therapies have comparable effect sizes. Also, it is not
known whether heterogeneity is low in these meta-analyses because the confidence levels around
I2 are typically wide.
Comparative outcome studies also have several other important methodological problems that
may affect their results.One substantial problem is statistical power.Differences between therapies
can be assumed to be small, and, therefore, comparative trials need large sample sizes. For example,
a rough estimate of the threshold for clinical relevance in depression, based on the minimally
important difference from the patient’s perspective, has been found to be d = 0.24 (Cuijpers et al.
2014b). In order to find such a difference, a trial would need 548 patients (274 in each condition;
Cuijpers 2016). Trials with such large sample sizes are hardly ever conducted in psychotherapy
research. In a meta-analysis of 46 outcome trials comparing CBT for depression with another
therapy, we found that the mean number of patients included was 52, and the range was 13 to 178
(Cuijpers et al. 2013). The largest trial (Dowrick et al. 2000) had sufficient power only to detect a
differential effect size of d = 0.42, and the average study with 52 patients had enough power only
to find a differential effect size of d = 0.79.
Another important problem is the low methodological quality of many trials. For example,
in a meta-analysis of controlled trials of psychotherapy for depression in adults we found that
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only 22% of the 289 studies could be rated as having a low risk of bias (Cuijpers et al. 2019b).
For anxiety disorders, we found that only 29% (9/31) of trials assessing treatment for generalized
anxiety disorder, 10% (4/42) of those for panic disorder, and 17% (8/48) of those for social anxiety
disorder had a low risk of bias (Cuijpers et al. 2016a). It is well known from controlled trials that
poor-quality trials considerably overestimate the effects of therapies (Cuijpers et al. 2010, 2019b;
Furukawa et al. 2014). It has not been examinedwhether the poor quality ofmany trials has affected
the outcomes of comparative outcome studies. However, the results of many comparative trials
may also be biased and may not accurately represent the true differentials between therapies.
In principle, the power problem of comparative outcome trials can be solved by pooling the
results of multiple trials in meta-analyses. However, if we focus only on trials with a low risk of
bias, then even meta-analyses do not have enough power to detect smaller differences between
therapies (Cuijpers 2016).
Alternative Explanations for Finding Comparable Outcomes
But suppose that all meta-analyses show that therapies have comparable effects and heterogene-
ity is low. Can that be considered as evidence for the common factors model? In general, there
is little empirical evidence about how therapies work (Kazdin 2007), so whether therapy works
through common factors is mostly a matter of speculation. There are alternative explanations
for why therapies may have comparable effects. One logical explanation is that many roads lead
to Rome, and different therapies may lead to comparable outcomes via different mechanistic
pathways (DeRubeis et al. 2005). Mental disorders are complex and affect many areas of life. If
a therapy—itself a multifactorial, complex process—focuses on one area of life and successfully
changes it, then it may in turn change the other areas that are affected by the disorder. For exam-
ple, depression is a disorder that affects cognitions, behavior, interpersonal relations, intrapersonal
functioning, and other areas. If someone learns how to change his or her cognitions and is success-
ful in doing so, then this change may also result in improvements in other areas. And if someone is
treated with a therapy that focuses on intrapersonal issues that may also affect all the other areas.
So in these cases it would mean that the outcomes of all therapies are comparable, but how they
realize their effects may still differ.
Related to this discussion of complex processes, mental disorders are significantly associated
with dozens of psychological, biological, and social factors. Therapies are also highly complicated
interactions between a therapist and a patient. So it is very possible, even probable, that there are
endless ways in which the therapy is shaped, with some interactions having an impact on specific
patients with certain characteristics. These interactions probably differ considerably for each
patient and each therapy. However, when these outcomes are taken together in trials and those
trials are pooled in a meta-analysis, the highly individual outcomes are blended into one outcome.
The lack of precision in measuring mental health problems and the outcomes of therapies makes
the therapeutic process seem even more uniform, when in fact, therapy is a highly individualized
process, and it is impossible to say whether these outcomes are the result of common or specific
factors.
The only conclusion we can draw frommeta-analyses of comparative outcome trials is that they
partly support the common factors model because some show comparable outcomes for therapies.
However, there is insufficient evidence to be certain whether all therapies do indeed have compa-
rable effects. And even if the final conclusion turns out to be that all therapies have comparable
effects, this cannot be seen as final proof that all therapies work through common factors, as we
have argued.
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COMPONENT STUDIES AND THE COMMON FACTORS MODEL
One important type of research that is used as an argument by proponents of specific therapymod-
els is the component study. These studies provide an elegant way to identify the active ingredients
of psychotherapies (Borkovec & Costonguay 1998). These studies decompose multicomponent
therapies and compare the full therapy with a therapy in which one component is left out (dis-
mantling studies) or in which a component is added to an existing therapy (additive studies; Bell
et al. 2013). Because of their design, the strength of evidence resulting from component studies is
high. If a component study finds a difference between a therapy with a component and a therapy
without that component, this indicates that the particular component is indeed responsible for (at
least part of) the effects of the intervention. Therefore, proponents of common factors assume
that component studies do not result in significant differences between studies with or without
a specific component, as long as both the therapy with the component and the one without are
bona fide.
There are a few meta-analytical studies of component studies. The first one, which included
27 studies, did not find evidence that specific components were responsible for part of the effects
of therapies (Ahn & Wampold 2001). In keeping with the common factors model, no significant
differences between therapies with and without specific components were found. A second major
review examined a much larger set of component studies (n = 66; Bell et al. 2013) and found that
the use of dismantling studies did not result in significant differences between the full and the
partial treatment (in which one component was left out; Cuijpers et al. 2019a). However, a small
but significant effect was found when a component was added to a therapy, and this effect was
larger at follow-up. This finding was not in keeping with the common factors model. A reanaly-
sis using longitudinal meta-analytical methods could not replicate the finding that the effects of
components were found in the long term (Flückiger et al. 2015,Wampold & Imel 2015). In a third
meta-analysis of 16 component studies of treatments for depression, a small but significant differ-
ence (SMD = 0.21) was found between the full treatments and treatments with one component
removed (Cuijpers et al. 2019a).
There are several methodological problemswith component studies thatmake themhard to in-
terpret and make it even harder to decide whether they support the common factors model. Again,
the first problem is statistical power. Just as with other comparative trials,most component studies
are heavily underpowered. In the meta-analysis by Cuijpers et al. (2019a), none of the studies had
more than 19% of the number of participants needed to detect the significant effect of a compo-
nent, and 16 of the 22 comparisons had less than 10% of the participants needed. The only excep-
tion was a study in which emotion regulation skills training was added to CBT for treating depres-
sion (Berking et al. 2013), and this study found a superior effect of CBT with emotion regulation
skills training compared to CBT without this training. In the same meta-analysis, three studies
compared cognitive restructuring plus behavioral activation for depression with cognitive restruc-
turing alone. These studies also found a significant effect of adding behavioral activation to cogni-
tive restructuring. In sum, these findings suggest that component studies may be suited to demon-
strating the significant effects of components, but they need sufficient power to be able to do so.
Again, another methodological problem is the risk of bias. As mentioned earlier, this refers to
the weak spots of a trial and, for example, to problems with the randomization and the blinding
of outcome assessors, and whether all randomized patients are included in the analyses (Cuijpers
& Cristea 2016). Of the 16 studies included in the meta-analysis by Cuijpers et al. (2019a), only 1
had a low risk of bias. This suggests that based on the literature, we are not able to state whether
specific components of therapies are essential elements or whether the effects result from common
factors.















































































































Model of the clinical change process and the components of psychotherapy.
In addition, it can be questioned whether the results of component studies should be pooled in
meta-analyses anyway.The components of therapies that are examined in these studies differ from
one another, and it is possible that a few components are essential components of therapies while
others are not. If the pooled result of all component studies finds no significant effect, then that
cannot be considered as evidence that essential components do not exist. Finding nonsignificant
effects of pooled component studies is not evidence that these components do not exist and that
therapies work through common elements.
HOW CAN SPECIFIC AND NONSPECIFIC FACTORS BE EXAMINED?
At the start of this review, we stated that RCTs result in strong evidence that a therapy works, but
it is much more complicated to show how a therapy works, and the trial designs used to examine
these mechanisms do not provide the same strength of evidence as results from RCTs. In this
section, we will explain this problem in more detail and describe the methods that can be used to
examine the mechanisms of therapies. These methods are important because this is the research
that can tell us whether it is the specific mechanisms, the nonspecific, or both that are responsible
for the change that results from therapies.
A Model for the Process of Clinical Change
In Figure 1 we present a simplified model of how therapies lead to clinical outcomes in patients.
This model is based on earlier work by Hollon and associates (1990) and builds on the definitions
of relevant concepts described by others (Borkovec & Sibrava 2005; Kazdin 2007, 2009; Kraemer
et al. 2008, 2002).
A therapy consists of several descriptive components, some of which may be inactive (e.g.,
they do not contribute to change in a patient) and others that are active (e.g., specific therapeutic
procedures). The active components are the specific or nonspecific factors, or both, of the therapy.
The mechanisms of change are the therapeutic processes or events that are responsible for the
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change and the reasons why change occurs or how change comes about (Kazdin 2007, 2009).
These are the results of the active components (i.e., therapeutic procedures) of the therapies.
Mechanisms of change happen in the patient, while the active components are part of the therapy.
Mechanisms of change can be influenced by events outside of therapy. These extratherapeutic
factors may include life events or a lack of competencies in the patient that limit the possibili-
ties of the mechanisms of change. Such effects are not so much a consequence of treatment as
an extraneous influence on outcome, unless they interact with treatment to produce the change
observed.
Moderators, or prognostic indices, are characteristics that influence the direction or magnitude
of the relationship between treatment and outcome (Kazdin 2007, 2009; Kraemer et al. 2008).
In our model, it is assumed that moderators are related to active components and mechanisms
of change. Moderators that are found to be statistically significant indicate that different active
components and mechanisms of change are involved in specific subgroups. For example, if an
RCT finds that gender is a significant moderator of outcome, this would imply that the active
components or subsequent mechanisms of change, or both, differ for men and women.
Mediators are intervening variables that statistically may account for the relationship between
the treatment and the outcome (Kazdin 2007). Mechanisms of change are expected to consist of
a mediator or a group of mediators. However, mediators are not necessarily part of a mechanism
of change because statistically they may account for only the association between treatment and
outcome. It is possible for a variable that is found to be a mediator to be, in fact, a proxy for
one or more other variables. A mediator may point to a possible causal mechanism, but it is not
necessarily part of the mechanism itself (Kazdin 2007).
Research Methods for Examining the Process of Clinical Change
RCTs showing that a therapy is effective are not sufficient to examine how treatments result in
clinical outcomes. This is similar to attempts to show that smoking leads to lung cancer (Kazdin
2007, 2009). Showing that such an association exists says nothing about the exact biological pro-
cesses in the human body that lead from the smoke being inhaled into the lungs to the development
of cancer over time.
We have already shown that component studies are a good option for examining the effective
ingredients of therapies because they provide strong evidence that the examined components are
indeed responsible for the effects of a treatment.However, component studies do not explain fully
how these treatments work. The components activate mechanisms of change in the patient, but
component studies do not identify what these mechanisms are or explain how they operate. In
order to examine mechanisms of change, it is necessary to examine mediators. Mediators are the
intervening variables that account for the relationship between the treatment and the outcome of
the treatment (Kazdin 2007). To show statistically that a variable is a mediator, several conditions
must be met (Baron & Kenny 1986, Kazdin 2007, Kraemer et al. 2008, MacKinnon et al. 2007).
First, participants in the intervention condition must show significantly greater decreases
in measures of symptoms over time than the controls (i.e., the treatment condition predicts
the change in the outcome). Second, participants in the intervention condition must show
significantly greater decreases on measures of the mediator over time than controls (i.e., the
treatment condition predicts changes in the mediator). Third, in the intervention condition,
the change in the mediator over time must be significantly correlated with change in the outcome
over time. And fourth, the predictive effect of the intervention condition on the change in the
outcome—after controlling for change in the mediator—must be significantly reduced (for partial
mediation) or eliminated (for complete mediation) relative to when the outcome is regressed
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only for the intervention condition. A decade ago, the MacArthur group (Kraemer et al. 2008)
proposed a somewhat different analytical approach that basically replicates this logic but adds the
notion that an interaction between a treatment and a purported mediator also indicates mediation
even in the absence of a documented relation between treatment and outcome.
Studies of mediators are not sufficient to examine mechanisms of change. If a mediator meets
the criteria described above, there is still not sufficient evidence of a causal association between
the mediator and the outcome. It is possible that a mediator is, in fact, a proxy for one or more
other variables. Furthermore, if a variable is indeed a mediator, it must be shown that changes in
the mediator come before changes in the outcome, thus demonstrating a temporal relationship.
To show that a mediator is indeed a component of a mechanism of change, several other types of
research are helpful, including direct experimental manipulation of the proposedmediator, studies
showing a dose–response relationship between the mediator and the outcome, and theoretical
studies presenting a plausible explanation for why and how the mediator results in change in the
patient (Kazdin 2007, 2009).Multiple, converging lines of research are needed to explain precisely
how mechanisms of change result in better outcomes for the patient.
To demonstrate how difficult it is to show how mechanisms of change actually work, we return
to the example of tobacco smoking. Although many carcinogens have been identified in tobacco,
and a considerable body of research has tried to disentangle how these substances cause cancer,
“we may never be able to map each detail of the complex process by which cigarette smoking
causes lung cancer” (Hecht 1999, p. 1194).
Research on Specific and Nonspecific Components of Therapies
There are two major groups of studies examining how therapies work: component studies and
studies directly examining mediators and working mechanisms. We have already showed that a
considerable number of component studies have been conducted during the past decades, but
their methodological weaknesses do not warrant drawing strong conclusions about whether there
are specific effects. The best conclusion is that this body of research is not strong enough to say
whether there are specific components.
Hundreds of studies have examined the processes that are active in psychotherapy. However,
the majority of these studies have examined only the association or correlation between the out-
come of a therapy and the characteristics of patients, the therapist, and the therapy process, and
they did not include formal tests of mediators. For example, one large meta-analysis included al-
most 200 studies examining the correlation between improvement in patients and the therapeutic
alliance (Horvath et al. 2011).
Many hundreds of other studies have examined the association between patients’ improvement
and expectations, the therapist’s warmth and mastery, and other characteristics (Orlinsky et al.
2004). However, this large body of research lacks the strength of evidence from RCTs and is only
correlational, with all of the pitfalls and limitations attached to that. One problem is that the
association between many of these factors and outcomes can be examined only within treatments
because factors related to the therapist and therapy are irrelevant in control conditions. This
means that these variables are completely integrated into the treatment and cannot be examined
in controlled trials. Furthermore, in order to plausibly discover whether these variables are indeed
mediators, we need to find a temporal association, with a change in the mediator preceding the
change in the outcome. Finding a dose–response relationship would strengthen the hypothesis
that a variable is indeed a mediator. But then it might still be possible that a third variable causes
a change in the outcome as well as a change in the assumed mediator. Even if a large number of
such third variables were to be examined (which is almost impossible to achieve because of the
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limited time patients can spend completing questionnaires), the possibility can never be excluded
that there is a third, unmeasured variable causing the change in the outcome and in the assumed
mediator. Only supporting evidence from experimental studies and a clear theoretical framework
can strengthen the hypothesis that a particular variable is indeed a mediator.
The complexity of showing whether specific or nonspecific factors are accountable for the ef-
fects of psychotherapy is complicated even further by the fact that many studies of psychotherapy
suffer from a considerable risk of bias, low statistical power, publication bias, and researcher al-
legiance. Furthermore, mental health problems and changes in these problems can be measured
only by self-report or by clinical interview: There are no objective tests. Together these problems
make it almost impossible to examine how therapies work, and it is not surprising that there is lit-
tle knowledge about this. Examining mechanisms of change requires considerable investment in
research, and unfortunately sufficient investment has not been available to disentangle the mech-
anisms of change in specific therapies. The implication is that we know only a little about whether
therapies work through specific or nonspecific factors.
EVIDENCE FOR SELECTED COMMON FACTORS
The Therapeutic Alliance
Of all the common factors that have been proposed, the therapeutic alliance or therapeutic rela-
tionship is championed by many as the most important. The alliance has three components: the
bond between the therapist and patient, agreement about the goals of therapy, and agreement
about the tasks of therapy (Wampold 2015). The association between alliance and outcome in
psychotherapy has been extensively examined in treatment studies, and the most recent meta-
analysis, based on more than 200 studies, found that stronger alliances are indeed associated with
better outcomes, although the magnitude of the association is modest, with an explained variance
in outcome of 7.5% (Horvath et al. 2011). The alliance–outcome association is often presented as
strong proof in favor of the common factors theory, despite the relatively modest magnitude of the
association and the fact that this association is merely correlational in nature. Correlational data
cannot be used for causal inferences, and a temporal relationship, a dose–response relationship,
the exclusion of other potential mediators, supporting experimental research, and an explanatory
theoretical framework are also needed to establish the role of the alliance in realizing change.
However, recent studies have begun to disentangle the relationship between alliance and
outcome. The core of this new line of research is the establishment of a time line of repeated
assessments so that temporality can be investigated, and this is combined with the use of advanced
statistical methods that account for potential confounders. Zilcha-Mano (2017) reviewed these
new studies in an elegant overview and concluded that the studies that account for temporality
and disentangle the effects of between- and within-patient variability show that changes in the
alliance may indeed precede symptom reduction. She proposes a new model for understanding
the potential therapeutic role as sufficient to induce change by itself. This model, based on the
integration of previous research (Zilcha-Mano 2017), stresses the importance of differentiating
between patients’ general tendencies to form satisfying relationships with others, which affect
also their relationship with the therapist (the trait-like component of alliance with which the
patient comes into the therapy), and the process of the development of changes in such tendencies
through interaction with the therapist (the state-like component of alliance that changes as a
result of therapy). A good trait-like alliance is a prerequisite to engaging in therapy and making it
effective, while the state-like changes in the alliance during treatment can predict the subsequent
outcome and, thus, might make the alliance therapeutic in itself.
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Zilcha-Mano (2017) also argues that disentangling the trait-like and state-like components
of the alliance might elucidate differences in the role of the alliance between therapy schools.
Indeed, in some therapies that place more emphasis on the alliance (e.g., psychodynamic therapy),
the alliance might be more strongly linked to outcome than in therapies that place less emphasis
on the alliance (e.g., CBT) (Huibers & Cuijpers 2015).
Despite the sophistication of Zilcha-Mano’s (2017) review, it should be emphasized that tem-
porality is only one of many criteria that should be met before speaking of a causal mechanism
(Kazdin 2007).The studies reviewed by Zilcha-Mano (2017) are definitely a step in the right direc-
tion, but they are observational and cannot be seen as proof of the causal role of the alliance in the
process of psychotherapy. For example, it is still entirely possible that a third, unmeasured variable
is driving the change in both the alliance and outcome, even if temporality is accounted for.
One more step toward evidence for a causal role of the alliance could come from experimental
studies, in which the alliance is isolated as a process and directlymanipulated. For example, one can
imagine a randomized experiment in which therapists in one condition are instructed to maintain
a steady alliance, while therapists in the second condition are instructed to actively strengthen the
alliance over the course of therapy (Zilcha-Mano 2017). In the case of the alliance, conducting
such experiments is challenging, primarily from an ethical point of view, but it is not entirely
impossible (Huibers & Cuijpers 2015).
Other Common Factors
In addition to the therapeutic alliance, a wide array of other common factors have been proposed
(Table 1; Lambert & Ogles 2004) and investigated in the context of treatment. Wampold (2015)
summarized the evidence in the form of aggregated effect sizes for common factors—such as
therapist empathy, patients’ expectations of outcome, the cultural adaptation of evidence-based
interventions (for an optimal fit with the patient’s beliefs about illness and effective therapy), and
the therapist’s effects—and concluded that they all should be considered therapeutic, although
the evidence in favor of specific factors is weak. However, this distinction between common and
specific factors is based purely on correlational data, and, therefore, it is not supported by evidence
for or against the potentially causal role of common or specific factors. Moreover, the differences
in effect sizes between nonspecific and specific factors that Wampold presents are questionable.
Factor–outcome correlations or effect sizes based on correlational data cannot be used to deter-
mine the relative importance of these factors, let alone to inform us about the causal impact of
therapy factors on outcome.
On the basis of several meta-analyses, the American Psychological Association’s Interdivisional
Task Force on Evidence-Based Therapy Relationships concluded that expressed empathy (Elliott
et al. 2011), the therapeutic alliance (Horvath et al. 2011), and collecting structured client feedback
(Lambert & Shimokawa 2011) were demonstrably effective elements of the therapeutic relation-
ship across all models of psychotherapy (Norcross &Wampold 2011). The complexities involved
in examining how therapies work make this an overly optimistic summary of the literature.
Specific Factors
Apart from the research on common factors, there is also a vast literature on the specific factors
that might account for the effects of psychotherapy, mostly organized around specific forms of
psychotherapy (mostly CBT) and specific psychological disorders (mostly depression and anxiety).
What can be said for the evidence on common factors can, broadly speaking, just as well be said for
the evidence on specific factors: Most older studies are correlational, and the number of studies is
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small that address temporal changes, dose–response relationships, and experimental manipulation
of putative mechanisms. It is beyond the scope of this article to present a complete overview of
these studies. However, we discuss a few recent reviews and meta-analyses that give an impression
of how this field has developed during the past decades, particularly in regard to CBT, the most
extensively researched form of psychotherapy.
Kazantzis et al. (2018) reviewed 30 meta-analyses that synthesized process–outcome relation-
ships in CBT (mostly used to treat depression and anxiety) that were categorized as involving ei-
ther treatment processes (e.g., cognitive change work) or in-session processes (e.g., the therapeutic
alliance). Note that the distinction between therapeutic procedures and therapeutic processes is
not made in this review. In the category of treatment processes, they found the strongest support
for cognitive and behavioral strategies as processes of change in CBT in depression and anxiety.
For in-session processes, the strongest support was found for the therapeutic alliance and home-
work assignments. At a glance, this comprehensive review seems to highlight the importance of
both specific and nonspecific factors. However, it should be kept in mind that the evidence re-
viewed is merely correlational.
Lemmens et al. (2016) reviewed the mechanisms of change in psychotherapy (CBT and other
forms of therapy) for depression.This review included 35 individual studies in which an actual test
of statistical mediation [using the methods of Baron & Kenny (1986) or more advanced methods]
was performed. In total, 39 different potential mediators (i.e., therapeutic processes) were inves-
tigated, mostly related to CBT and CBT processes. The strongest support was found for changes
in dysfunctional attitudes, negative automatic thoughts, rumination, worry, and the use of mind-
fulness skills, but it should also be noted that about half of the studies did not detect a mediational
role for the construct under investigation. Moreover, Lemmens and associates (2016) also inves-
tigated the quality of these mediation studies based on six methodological criteria (RCT design,
inclusion of a control group, sufficient sample size, assessment of multiple mediators, temporality,
and experimental manipulation) and found that only 17 out of 35 studies met 4 or more of these
criteria. Their conclusion is that the evidence for the mediational role of the various constructs
(specific and nonspecific) is largely mixed and that better designed studies are urgently needed to
understand the mechanisms of psychotherapy.
Cristea et al. (2015) performed a meta-analysis of the effects of CBT on dysfunctional think-
ing (the presumed core process in CBT) compared with the effects on dysfunctional thinking in
control groups, other forms of psychotherapy and antidepressant medication. They included 26
studies, of a less-than-optimal quality, and found a strong association between the effects of CBT
on dysfunctional thinking and the effects on depression. However, the effects on dysfunctional
thinking did not differ significantly between CBT and other psychotherapies (except when the
comparison was restricted to a specific measure, the Dysfunctional Attitude Scale, or DAS) or
antidepressant medication, suggesting that the effect on dysfunctional thinking is not specific or
exclusive to CBT. The authors concluded that their findings can be interpreted in opposite direc-
tions: as a confirmation of the primacy of cognitive change as a specific factor in symptom change,
regardless of how it is attained, or as support for the notion that dysfunctional thinking is merely
another symptom of depression that changes during therapy.
Similar to the review by Cristea et al. (2015), Spinhoven et al. (2018) conducted a meta-analysis
of 36 studies that investigated the effects of various forms of CBT on repetitive negative thinking
(i.e., rumination) compared with control groups and other treatments. They found a medium-size
effect of any treatment compared with the control group, but they also found significantly larger
effect sizes for CBT treatments such as rumination-focused CBT and original CBT compared
with treatments such as antidepressant medication and counseling. The authors concluded that
CBT and, in particular, rumination-focused CBT might have specific and pronounced effects
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on repetitive thinking, which might be interpreted as establishing a link between a therapeutic
procedure (i.e., specific CBT interventions) and a therapeutic process (i.e., rumination).
In sum, the association between specific factors and outcome is well established, especially in
the field of CBT, but proof of the causal role of these factors is generally lacking, and there is
insufficient evidence that these specific factors are core elements of how CBT works. More than
30 years after the introduction ofmediation analysis (Baron&Kenny 1986),wemust conclude that
we still do not know whether the factors that bring about change in psychotherapy are specific,
nonspecific, or both. New lines of research are needed that account for temporality and other
criteria that constitute the requirements for establishing a causal link. Moreover, by definition,
psychotherapy is a complex process involving multiple elements that most likely interact with one
another, and simple causal models probably will not advance our understanding of how it works
(Lemmens et al. 2016, Lorenzo-Luaces & DeRubeis 2018).
RECOMMENDATIONS FOR FUTURE RESEARCH
Research on common and specific factors, and understanding how therapies bring about change in
patients, is important, not only from a scientific perspective but also from a public health view. For
example, the effect sizes of treatments in depression have not increased during the past decades,
and many patients do not respond to treatment or relapse soon after recovery. Furthermore, the
uptake of therapies is low, even in high-income countries (Chisholm et al. 2016), and one reason
may be that therapies are not sufficiently acceptable to patients. Understanding how therapies
work may make it possible to develop treatments that focus on the core processes and are, there-
fore, more effective and efficient, and more acceptable to patients.
Until now, much research has focused on RCTs, with many hundreds of such trials showing
that therapies work but not how they work. There is also a lot of research on the processes and
potential working mechanisms of therapies. However, this large body of research consists mostly
of correlational research, and few studies have focused on the type of research that is needed
to show precisely how these mechanisms work, with evaluations of the temporal associations, the
dose–response relationship, and the other requirements of such research.This means that we have
conducted a large number of studies examining how therapies work but have never managed to
focus this research on the issues that are needed to understand the mechanisms of change. It is as
if we have been in the pilot phase of research for five decades without being able to dig deeper.
If we want to take a step forward, we need to conduct research that goes beyond examining,
on the one hand, simple correlational associations between specific and common factors and, on
the other, outcomes.We need research on these factors that includes temporal associations, dose–
response relationships, multiple alternative potential mediators, experimental manipulation, and
theoretical models. Research to discover how one type of therapy works and whether a specific or
a common factor is responsible for change requires major funding, many individual studies, and
a deep breath. There are no easy solutions, and such research will require considerable resources.
However, we have invested resources in this research for five decades and if we could put only
part of these resources toward making a coordinated effort to examine mechanisms of change, it
would certainly become feasible.
Within such broad frameworks, it is important to conduct research with carefully planned as-
sessments of both procedures (i.e., the interventions employed by the therapist) and treatment pro-
cesses (i.e., the changes that occur within the patient as a result of those interventions). Although
therapeutic procedures and processes have often been lumped together as mechanisms of change,
it is important to differentiate between them and examine them and their interplay in detail.
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Accounting for individual differences between patients is vital in this research. Causal path-
ways of change are likely to differ between patients. Although RCTs focus mainly on groups and
mean values for the group, trial data can be used to investigate individual differences. One way to
approach the issue of “different strokes for different folks” is to analyze moderated mediation. For
example, recent studies have shown that the alliance may indeed be a predictor of outcome but
only in certain subgroups of patients (Lorenzo-Luaces et al. 2014, 2015; Zilcha-Mano et al. 2018).
Another important element that studies should address is not only between-person variability
(e.g., a good versus bad alliance) but also within-person variance (e.g., change in the alliance over
time) to assess how changes within a patient during the course of treatment lead to individual out-
comes. It may be helpful to use advanced methods such as experience sampling (see, for example,
Hoet et al. 2018) to track the change processes of individual patients before and during treatment
so that these can then be linked to outcome.
CONCLUSIONS
Although it has been shown that psychotherapies are effective in treating mental disorders, how
they work is not well understood. Examining how therapies work cannot be done with RCTs
alone, and the analysis requires multiple, complicated, and very large studies that should be com-
plemented by experimental studies and theoretical work. Psychotherapies may work through tech-
niques that are specific to each therapy or through factors that all therapies have in common, but
currently, there is insufficient evidence to enable either common factors or specific factors to ex-
plain how therapies work. Proponents of the common factors model often point to other evidence
to show that these factors are, in fact, the ones that make therapies work. One important body of
knowledge consists of comparative outcome studies, which have suggested that all therapies have
comparable effects. However, not all meta-analyses support the common factors model; the stud-
ies included in them often have methodological problems; and there are alternative explanations
for finding comparable outcomes. Component studies, in which one component is added to or
removed from a therapy, are assumed by proponents of the common factors model to result in
nonsignificant differences between the full and the partial therapies. However, these studies are
typically underpowered, and there are few sufficiently powered component studies, meaning that
this body of research also cannot tell us whether therapies work through common or specific
factors.
Psychotherapy is a complex, multifactorial process, and it is most likely that both common
factors and specific factors play a part in the process that leads to recovery, most likely in com-
plicated ways that cannot be captured by simple causal models. That being said, the only empir-
ical conclusion that can be drawn is that it is not known whether therapies work through com-
mon factors, specific factors, or both, and that more and better research is needed to establish
this.
SUMMARY POINTS
1. Although hundreds of randomized controlled trials have shown that psychotherapies are
effective in treating mental disorders, it is not known how they work.
2. Therapiesmaywork through techniques that are specific to each therapy, through factors
that all therapies have in common, or through a combination of the two.
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3. The discussion about whether therapies work through common or specific mechanisms
has been going on for several decades, but it has not been resolved because it is not
known how therapies work.
4. Meta-analyses of comparative outcome studies do not all point to comparable effects
for different therapies and because alternative explanations are possible for comparable
effects, it is not known whether all therapies do, in fact, have comparable effects.
5. Component studies (in which one component is removed from or added to a therapy and
this is compared with the complete therapy) are also inconclusive, regardless of whether
specific components are partly responsible for the effects of therapies.
6. There is no straightforward method for examining how therapies work, and most re-
search on specific and common factors has been conducted using correlational studies;
there has been little research on temporal associations, dose–response relationships, sup-
portive theoretical frameworks, and laboratory studies.
7. Although hundreds of correlational studies have been conducted during the past decades,
little progress has been made in understanding the mechanisms of change of therapies:
It is as if we have been in a pilot phase of research for five decades.
FUTURE ISSUES
1. We must realize that examining how a therapy works is completely different from ex-
amining that it works.
2. To come to an understanding of how a therapy works requires major funding, many
individual studies, and a deep breath.
3. Moderated mediation is a promising focus of future research.
4. Research should focus not only on between-person variability but also on within-person
variance, for example, with experience sampling methods.
DISCLOSURE STATEMENT
The authors are not aware of any affiliations, memberships, funding, or financial holdings that
might be perceived as affecting the objectivity of this review.
ACKNOWLEDGMENTS
The authors thank Erika Kuzminskaité for her assistance with the systematic review of meta-
analyses of comparative trials.
LITERATURE CITED
Ahn H, Wampold BE. 2001. Where oh where are the specific ingredients? A meta-analysis of component
studies in counseling and psychotherapy. J. Counsel. Psychol. 48:251–57
Baardseth TP, Goldberg SB, Pace BT, Wislocki AP, Frost ND, et al. 2013. Cognitive-behavioral therapy
versus other therapies: redux. Clin. Psychol. Rev. 33:395–405



























































































CP15CH09_Cuijpers ARjats.cls March 30, 2019 14:8
Baron RM, Kenny DA. 1986. The moderator–mediator variable distinction in social psychological research:
conceptual, strategic, and statistical considerations. J. Personal. Soc. Psychol. 51:1173–82
Barth J,Munder T,GergerH,Nuesch E,Trelle S, et al. 2013.Comparative efficacy of seven psychotherapeutic
interventions for patients with depression: a network meta-analysis. PLOS Med. 10:e1001454
Bell EC, Marcus DK, Goodlad JK. 2013. Are the parts as good as the whole? A meta-analysis of component
treatment studies. J. Consult. Clin. Psychol. 81:722–36
Berking M, Ebert D, Cuijpers P, Hofmann SG. 2013. Emotion regulation skills training enhances the efficacy
of inpatient cognitive behavioral therapy for major depressive disorder: a randomized controlled trial.
Psychother. Psychosom. 82:234–45
Bisson JI, Roberts NP, Andrew M, Cooper R, Lewis C. 2013. Psychological therapies for chronic post-
traumatic stress disorder (PTSD) in adults. Cochrane Database Syst. Rev. 12:CD003388
Borkovec TD, Costonguay LG. 1998. What is the scientific meaning of empirically supported therapy?
J. Consult. Clin. Psychol. 66:136–42
Borkovec TD, Sibrava NJ. 2005. Problems with the use of placebo conditions in psychotherapy research,
suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. J. Clin. Psychol.
61:805–18
Braun SR, Gregor B, Tran US. 2013. Comparing bona fide psychotherapies of depression in adults with two
meta-analytical approaches. PLOS ONE 8:e68135
Budd R, Hughes I. 2009. The Dodo Bird Verdict—controversial, inevitable and important: a commentary on
30 years of meta-analyses. Clin. Psychol. Psychother. 16:510–22
Carroll L. (1865) 1998. Alice’s Adventures in Wonderland. Chicago, IL: VolumeOne
Chatterton ML, Stockings E, Berk M, Barendregt JJ, Carter R,Mihalopoulos C. 2017. Psychosocial therapies
for the adjunctive treatment of bipolar disorder in adults: networkmeta-analysis.Br. J.Psychiatry 210:333–
41
Chen L, Zhang G, Hu M, Liang X. 2015. Eye movement desensitization and reprocessing versus cognitive-
behavioral therapy for adult posttraumatic stress disorder: systematic review and meta-analysis. J. Nerv.
Mental Dis. 203:443–51
Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, et al. 2016. Scaling-up treatment of depression and
anxiety: a global return on investment analysis. Lancet Psychiatry 3:415–24
Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. 2017. Efficacy of psychotherapies
for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry 74:319–
28
Cristea IA, Huibers MJH, David D, Hollon SD, Andersson G, Cuijpers P. 2015. The effects of cognitive
behavior therapy for adult depression on dysfunctional thinking: ameta-analysis.Clin. Psychol. Rev.42:62–
71
Cristea IA, Ioannidis JPA. 2018. Improving disclosure of financial conflicts of interest for research on psy-
chosocial interventions. JAMA Psychiatry 75:355–65
Cuijpers P. 1998. Minimising interventions in the treatment and prevention of depression: taking the conse-
quences of the ‘Dodo Bird Verdict.’ J. Mental Health 7:355–65
Cuijpers P. 2016. Are all psychotherapies equally effective in the treatment of adult depression? The lack of
statistical power of comparative outcome studies. Evid. Based Mental Health 19:39–42
Cuijpers P, Berking M, Andersson G,Quigley L, Kleiboer A, Dobson KS. 2013. A meta-analysis of cognitive-
behavioural therapy for adult depression, alone and in comparison with other treatments. Can. J. Psychi-
atry 58:376–85
Cuijpers P, Cristea IA. 2016. How to prove that your therapy is effective, even when it is not: a guideline.
Epidemiol. Psychiatr. Sci. 25:428–35
Cuijpers P, Cristea IA, Karyotaki E, Reijnders M, Hollon SD. 2019a. Component studies of psychological
treatments of adult depression: a systematic review and meta-analysis. Psychother. Res. 29(1):15–29
Cuijpers P, Cristea IA, Karyotaki E, Reijnders M, Huibers MJ. 2016a. How effective are cognitive behavior
therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World
Psychiatry 15:245–58



























































































CP15CH09_Cuijpers ARjats.cls March 30, 2019 14:8
Cuijpers P, deWit L,Kleiboer A,Karyotaki E,Ebert DD. 2018. Problem-solving therapy for adult depression:
an updated meta-analysis. Eur. Psychiatry 48:27–37
Cuijpers P, Donker T, Weissman MM, Ravitz P, Cristea IA. 2016b. Interpersonal psychotherapy for mental
health problems: a comprehensive meta-analysis. Am. J. Psychiatry 173:680–87
Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G. 2012. The efficacy of non-directive
supportive therapy for adult depression: a meta-analysis. Clin. Psychol. Rev. 32:280–91
Cuijpers P, Karyotaki E, Reijnders M, Ebert DD. 2019b. Was Eysenck right after all? A reassessment of the
effects of psychotherapy for adult depression. Epidemiol. Psychiatr. Sci. 28(1):21–30
Cuijpers P, Sijbrandij M, Koole S, Huibers M, Berking M, Andersson G. 2014a. Psychological treatment of
generalized anxiety disorder: a meta-analysis. Clin. Psychol. Rev. 34:130–40
Cuijpers P, Turner EH, Koole SL, van Dijke A, Smit F. 2014b.What is the threshold for a clinically relevant
effect? The case of major depressive disorders.Depress. Anxiety 31:374–78
Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G. 2010. The effects of psychotherapy for
adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol. Med. 40:211–
23
Cusack K, Jonas DE, Forneris CA, Wines C, Sonis J, et al. 2016. Psychological treatments for adults with
posttraumatic stress disorder: a systematic review and meta-analysis. Clin. Psychol. Rev. 43:128–41
DeRubeis RJ, Brotman MA, Gibbons CJ. 2005. A conceptual and methodological analysis of the nonspecifics
argument. Clin. Psychol. Sci. Pract. 12:174–83
Dowrick C, Dunn G, Ayuso-Mateos JL, Dalgard OS, Page H, Lehtinen V. 2000. Problem solving treatment
and group psychoeducation for depression: multicentre randomised controlled trial. BMJ 321:1450–
54
Driessen E, Hegelmaier LM, Abbass AA, Barber JP, Dekker JJM, et al. 2015. The efficacy of short-term
psychodynamic psychotherapy for depression: a meta-analysis update. Clin. Psychol. Rev. 42:1–15
Elliott R, Bohart AC,Watson JC, Greenberg LS. 2011. Empathy. In Psychotherapy Relationships That Work, ed.
J Norcross, pp. 132–52. New York: Oxford Univ. Press. 2nd ed.
Flückiger C, Del Re AC, Wampold BE. 2015. The sleeper effect: artifact or phenomenon—a brief comment
on Bell et al. 2013. J. Consult. Clin. Psychol. 83:438–42
Frank JD. 1961. Persuasion and Healing: A Comparative Study of Psychotherapy. Baltimore, MD: Johns Hopkins
Univ. Press
Furukawa TA, Noma H, Caldwell DM, Honyashiki M, Shinohara K, et al. 2014. Waiting list may be a no-
cebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatr. Scand.
130:181–92
Gelso C. 2014. A tripartite model of the therapeutic relationship: theory, research, and practice.Psychother. Res.
24:117–31
GergerH,MunderT,Gemperli A,NüeschE,Trelle S, et al. 2014. Integrating fragmented evidence by network
meta-analysis: relative effectiveness of psychological interventions for adults with post-traumatic stress
disorder. Psychol. Med. 44:3151–64
Gloaguen V,Cottraux J, Cucherat M, Blackburn I-M. 1998. A meta-analysis of the effects of cognitive therapy
in depressed patients. J. Affect. Disord. 49:59–72
Godfrey KM,Gallo LC, Afari N. 2015.Mindfulness-based interventions for binge eating: a systematic review
and meta-analysis. J. Behav. Med. 38:348–62
Grenon R, Carlucci S, Brugnera A, Schwartze D, Hammond N, et al. 2018. Psychotherapy for eating
disorders: a meta-analysis of direct comparisons. Psychother. Res. In press. https://doi.org/10.1080/
10503307.2018.1489162
Hecht SS. 1999. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91:1194–210
Higgins JPT, Altman DG,Gøtzsche PC, Jüni P,Moher D, et al. 2011. The Cochrane Collaboration’s tool for
assessing risk of bias in randomised trials. BMJ 343:d5928
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ
327:557–60
Hoet AC, Burgin CJ, Eddington KM, Silvia PJ. 2018. Reports of therapy skill use and their efficacy in daily
life in the short-term treatment of depression. Cogn. Ther. Res. 42:184–92



























































































CP15CH09_Cuijpers ARjats.cls March 30, 2019 14:8
Hollon SD, Evans MD, DeRubeis RJ. 1990. Cognitive mediation of relapse prevention following treatment
for depression: implications of differential risk. In Contemporary Psychological Approaches to Depression, ed.
RE Ingram, pp. 117–36. Boston: Springer
Horvath AO, Del Re AC, Flückiger C, Symonds D. 2011. Alliance in individual psychotherapy. Psychotherapy
48:9–16
Huibers MJ, Cuijpers P. 2015. Common (nonspecific) factors in psychotherapy. In The Encyclopedia of Clinical
Psychology, ed. RL Cautin, SO Lilienfeld, pp. 1–6. New York: Wiley
Ioannidis JPA, Patsopoulos NA, Evangelou E. 2007. Uncertainty in heterogeneity estimates in meta-analyses.
BMJ 335:914–16
Kazantzis N, Luong HK, Usatoff AS, Impala T, Yew RY, Hofmann SG. 2018. The processes of cognitive
behavioral therapy: a review of meta-analyses. Cogn. Ther. Res. 42:349–57
Kazdin AE. 2007. Mediators and mechanisms of change in psychotherapy research. Annu. Rev. Clin. Psychol.
3:1–27
Kazdin AE. 2009. Understanding how and why psychotherapy leads to change. Psychother. Res. 19:418–28
Kivlighan DM, Goldberg SB, Abbas M, Pace BT, Yulish NE, et al. 2015. The enduring effects of psychody-
namic treatments vis-à-vis alternative treatments: a multilevel longitudinal meta-analysis. Clin. Psychol.
Rev. 40:1–14
KraemerHC,KiernanM,EssexM,KupferDJ. 2008.How andwhy criteria definingmoderators andmediators
differ between the Baron & Kenny and MacArthur approaches.Health Psychol. 27(Suppl.):S101–8
Kraemer HC,Wilson GT, Fairburn CG, Agras WS. 2002. Mediators and moderators of treatment effects in
randomized clinical trials. Arch. Gen. Psychiatry 59:877–83
Kriston L, Wolff A, Westphal A, Hölzel LP, Härter M. 2014. Efficacy and acceptability of acute treatments
for persistent depressive disorder: a network meta-analysis.Depress. Anxiety 31:621–30
Lambert MJ. 1992. Psychotherapy outcome research: implications for integrative and eclectical therapists. In
Handbook of Psychotherapy Integration, ed. JCNorcross,MRGoldfield, pp. 94–129.New York: Basic Books
Lambert MJ, Ogles BM. 2004. The efficacy and effectiveness of psychotherapy. In Bergin and Garfield’s Hand-
book of Psychotherapy and Behavior Change, ed. MJ Lambert, pp. 139–93. New York: Wiley
Lambert MJ, Shimokawa K. 2011. Collecting client feedback. Psychotherapy 48:72–79
Leichsenring F, Rabung S. 2011. Long-term psychodynamic psychotherapy in complex mental disorders:
update of a meta-analysis. Br. J. Psychiatry 199:15–22
Lemmens LH, Müller VN, Arntz A, Huibers MJ. 2016. Mechanisms of change in psychotherapy for depres-
sion: an empirical update and evaluation of research aimed at identifying psychological mediators. Clin.
Psychol. Rev. 50:95–107
Leykin Y,DeRubeis RJ. 2009.Allegiance in psychotherapy outcome research: separating association from bias.
Clin. Psychol. Sci. Pract. 16:54–65
Linde K, Rücker G, Sigterman K, Jamil S, Meissner K, et al. 2015. Comparative effectiveness of psycholog-
ical treatments for depressive disorders in primary care: network meta-analysis. BMC Fam. Pract. 16:
103
Lorenzo-Luaces L, DeRubeis RJ. 2018. Miles to go before we sleep: advancing the understanding of psy-
chotherapy by modeling complex processes. Cogn. Ther. Res. 42:212–17
Lorenzo-Luaces L,DeRubeis RJ,WebbCA. 2014.Client characteristics as moderators of the relation between
the therapeutic alliance and outcome in cognitive therapy for depression. J. Consult. Clin. Psychol. 82:368–
73
Lorenzo-Luaces L, German RE, DeRubeis RJ. 2015. It’s complicated: the relation between cognitive change
procedures, cognitive change, and symptom change in cognitive therapy for depression.Clin. Psychol. Rev.
41:3–15
Luborsky L, Rosenthal R, Diguer L, Andrusyna TP, Berman JS, et al. 2002. The Dodo Bird Verdict is alive
and well—mostly. Clin. Psychol. Sci. Pract. 9:2–12
MacKinnon DP, Fairchild AJ, Fritz MS. 2007. Mediation analysis. Annu. Rev. Psychol. 58:593–614
Marcus DK, O’Connell D, Norris AL, Sawaqdeh A. 2014. Is the Dodo bird endangered in the 21st century?
A meta-analysis of treatment comparison studies. Clin. Psychol. Rev. 34:519–30



























































































CP15CH09_Cuijpers ARjats.cls March 30, 2019 14:8
Mayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, et al. 2014. Psychological and pharmacological
interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. Lancet
Psychiatry 1:368–76
MohrDC,Ho J,Hart TL,Baron KG,BerendsenM, et al. 2014.Control condition design and implementation
features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Transl.
Behav. Med. 4:407–23
Munder T, Brütsch O, Leonhart R,Gerger H, Barth J. 2013. Researcher allegiance in psychotherapy outcome
research: an overview of reviews. Clin. Psychol. Rev. 33:501–11
Munder T,GergerH,Trelle S, Barth J. 2011.Testing the allegiance bias hypothesis: a meta-analysis.Psychother.
Res. 21:670–84
Norcross JC, Wampold BE. 2011. Evidence-based therapy relationships: research conclusions and clinical
practices. Psychotherapy 48:98–102
Olatunji BO, Davis ML, Powers MB, Smits JA. 2013. Cognitive-behavioral therapy for obsessive–compulsive
disorder: a meta-analysis of treatment outcome and moderators. J. Psychiatr. Res. 47:33–41
Orlinsky DE, Ronnestad MH, Willutzki U. 2004. Fifty years of psychotherapy process–outcome research:
continuity and change. In Bergin and Garfield’s Handbook of Psychotherapy and Behavior Change, ed. MJ
Lambert, pp. 307–89. New York: Wiley
OudM,Mayo-Wilson E, Braidwood R, Schulte P, Jones SH, et al. 2016. Psychological interventions for adults
with bipolar disorder: systematic review and meta-analysis. Br. J. Psychiatry 208:213–22
Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. 2018. Psychological therapies for panic
disorder with or without agoraphobia in adults: a network meta-analysis. BJPsych Adv. 24:2
Rosenzweig S. 1936. Some implicit common factors in diverse methods of psychotherapy. Am. J. Orthopsychi-
atry 6:412–15
Shinohara K, Honyashiki M, Imai H, Hunot V, Caldwell DM, et al. 2013. Behavioural therapies versus other
psychological therapies for depression. Cochrane Database Syst. Rev. 16:CD008696
Skapinakis P, Caldwell DM,Hollingworth W, Bryden P, Fineberg NA, et al. 2016. Pharmacological and psy-
chotherapeutic interventions for management of obsessive–compulsive disorder in adults: a systematic
review and network meta-analysis. Lancet Psychiatry 3:730–39
Slade E, Keeney E, Mavranezouli I, Dias S, Fou L, et al. 2018. Treatments for bulimia nervosa: a network
meta-analysis. Psychol. Med. 6:1–8
Spinhoven P, Klein N,Kennis M,Cramer AO, Siegle G, et al. 2018. The effects of cognitive-behavior therapy
for depression on repetitive negative thinking: a meta-analysis. Behav. Res. Ther. 106:71–85
Steinert C, Munder T, Rabung S, Hoyer J, Leichsenring F. 2017. Psychodynamic therapy: as efficacious as
other empirically supported treatments? A meta-analysis testing equivalence of outcomes. Am. J. Psychi-
atry 174:943–53
Turner DT, van der Gaag M, Karyotaki E, Cuijpers P. 2014. Psychological interventions for psychosis: a
meta-analysis of comparative outcome studies. Am. J. Psychiatry 171:523–38
Velthorst E, Koeter M, Van Der Gaag M, Nieman DH, Fett A-K, et al. 2015. Adapted cognitive-behavioural
therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression.
Psychol. Med. 45:453–65
Wampold BE. 2001. The Great Psychotherapy Debate: Models, Methods, and Findings. Mahwah, NJ: Lawrence
Erlbaum
Wampold BE. 2015. How important are the common factors in psychotherapy? An update.World Psychiatry
14:270–77
Wampold BE, Imel ZE. 2015.Great Psychotherapy Debate: The Evidence forWhatMakes PsychotherapyWork.New
York: Routledge. 2nd ed.
Wampold BE, Minami T, Baskin TW, Callen Tierney S. 2002. A meta-(re)analysis of the effects of cognitive
therapy versus “other therapies” for depression. J. Affect. Disord. 68:159–65
Wampold BE,Mondin GW,Moody M, Stich F, Benson K, Ahn H. 1997. A meta-analysis of outcome studies
comparing bona fide psychotherapies: empirically, “all must have prizes.” Psychol. Bull. 122:203–15



























































































CP15CH09_Cuijpers ARjats.cls March 30, 2019 14:8
Westen D, Novotny CM, Thompson-Brenner H. 2004. The empirical status of empirically supported psy-
chotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychol. Bull. 130:631–
63
Zilcha-Mano S. 2017. Is the alliance really therapeutic? Revisiting this question in light of recent method-
ological advances. Am. Psychol. 72:311–25
Zilcha-Mano S, Lipsitz I, Errázuriz P. 2018.When is it effective to focus on the alliance? Analysis of a within-
client moderator. Cogn. Ther. Res. 42:159–71
































































































Positive Psychology: A Personal History
Martin E.P. Seligman                                                                          1
History of Psychopharmacology
Joel T. Braslow and Stephen R. Marder                                                     25
Bifactor and Hierarchical Models: Specification, Inference,
and Interpretation
Kristian E. Markon                                                                           51
The Utility of Event-Related Potentials in Clinical Psychology
Greg Hajcak, Julia Klawohn, and Alexandria Meyer                                       71
An Active Inference Approach to Interoceptive Psychopathology
Martin P. Paulus, Justin S. Feinstein, and Sahib S. Khalsa                               97
Implicit Cognition and Psychopathology: Looking Back and Looking
Forward
Bethany A. Teachman, Elise M. Clerkin, William A. Cunningham,
Sarah Dreyer-Oren, and Alexandra Werntz                                            123
The MMPI-2-Restructured Form (MMPI-2-RF): Assessment of
Personality and Psychopathology in the Twenty-First Century
Martin Sellbom                                                                               149
Normal Versus Pathological Mood: Implications for Diagnosis
Ayelet Meron Ruscio                                                                          179
The Role of Common Factors in Psychotherapy Outcomes
Pim Cuijpers, Mirjam Reijnders, and Marcus J.H. Huibers                              207
One-Session Treatment of Specific Phobias in Children: Recent
Developments and a Systematic Review
Thompson E. Davis III, Thomas H. Ollendick, and Lars-Göran Öst                     233
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